Jim Cramer shared his take on various stocks from callers, including this retail play with more ways to win than one. » Read More
Stocks opened lower Wednesday, the last trading day of the quarter, after a surprise drop in the ADP jobs report.
Futures dropped about 4 points as the ADP Employment report showed a decline of 23,000 jobs, well below expectations of a gain of 40,000 jobs. Treasury yields declined, and the dollar weakened. Bulls are already noting that the ADP report "does not incorporate a weather related rebound that could be present in this month's BLS data," so there is no reason to abandon the projections for healthy gains when the March jobs report comes out Friday.
It's all about jobs and rising interest rates in the week ahead—and the two are not unrelated. The March employment report next week is expected to show the first real signs of job growth since the recovery began.
Stocks are nearly 70 percent higher than when they hit their trough this time last year, and the street is as divided as ever about whether the rally will endure.
Over the past 6 months shares of CVS are down about 5%, while rival Rite Aid is down 22%. Should you swallow hard and buy?
Many on Wall Street believe what happens in January dictates trading for the rest of the year—the so-called January effect. So what should investors expect this month? Peter Boockvar, equity strategist at Miller Tabak, and Stephen Wood, chief market strategist at Russell Investments, shared their views.
Stocks rallied on the first trading day of the New Year, so will the trend continue throughout the year? Jason Trennert, chief investment strategist and managing partner at Strategas Research Partners and Kelly Campbell, founder and principal of Campbell Wealth Management shared their market outlooks.
What follows is a roundup of corporate earnings reports for Thursday, Dec. 17
Bernanke is expected to renominated into office on Thursday, but he has his critics; some who have blasted Time's magazine's choice of the Fed Chief as "Person of the Year."
Here is a roundup of corporate earnings reports for Thursday, Sept. 24.
There were four REIT IPOs scheduled to price this week and next, all designed to pick at the carcasses of commercial and residential properties, most of it on the mortgage side. So far, only two have priced, both of those a day late, and both raised half what they anticipated.
Key events and data to look out for on Thursday.
The trend for stocks continues to point up and could stay that way through the end of September, even if there are some choppy days.
Some of the market’s key drivers could rise or fall based on these quarterly numbers, the Mad Money host says.
Until last fall we were a nation that shopped until we dropped. Will back-to-school shopping season be a catalyst to get shoppers off the sidelines? An annual survey released today by Deloitte suggests the answer is yes.
Stocks bounced back from a swine flu-induced drop Monday as traders scooped up shares of drug makers and pharmacies.
Great. As if the bank stress test wasn't confusing enough, as if the auto restructuring wasn't enough uncertainty, now we have half of the trading community frantically Googling "Tamiflu" this morning. The concern is that swine flu this could create another slowdown in global travel just as we are trying to figure out a bottom. Commodities, airlines, and hotels are weak this morning.
Drugstore operator Rite Aid says its loss more than doubled in the fiscal fourth quarter after the company was forced to write off all its goodwill.
The fate of an important accounting rule will have a big impact on markets Thursday and beyond. It's not just any accounting rule. It's the highly controversial mark-to-market rule, criticized for the massive write downs in the banking industry.
In Moody’s “U.S. Bottom Rung” report, the ratings agency lists the 283 speculative-grade, non-financial U.S. companies most at risk of default. Check out the list.